Search - tctmd.com

Displaying 301 - 320 of 415

Sort: Relevancy | Date

News Conference News TCT 2014

AUC ‘Here to Stay’ but Should Evolve, Expert Says

September 15, 2014

Presentation TCT 2014

YES: PRAMI Proved This - Time to Change the Guidelines!

Presenter: Keith G. Oldroyd

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

MOC is an Unproven Initiative and a Waste of Time and Money!

Presenter: Jessica L. Mega, Daniel I. Simon, Paul S. Teirstein

September 14, 2014

Presentation TCT 2014

MOC is Grounded in Learning/Education Theory and Improves Clinical Outcomes!

Presenter: Jessica L. Mega, Daniel I. Simon, James E. Tcheng

September 14, 2014

Presentation TCT 2014

Social Media and the Internet: How to Make it Work for You and Your Career

Presenter: John Mandrola

September 14, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

Presentation TCT 2014

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher

September 13, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

Guidelines for Commercial TAVR Site Selection in the United States

Presenter: Rhonda Robb

October 31, 2013

Presentation TCT 2013

Medical Device Industry Perspectives

Presenter: Michael Mussallem

October 30, 2013

Presentation TCT 2013

From Evidence-Based Medicine to Guidelines (and Appropriate Use Criteria) to Clinical Practice

Presenter: Robert Harrington

October 30, 2013

Presentation TCT 2013

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Presenter: Martin Leon

October 30, 2013

Presentation TCT 2013

Status Update on European Medical Device Regulatory Reform Initiatives

Presenter: Alan Fraser

October 30, 2013

Advertisement

AUC ‘Here to Stay’ but Should Evolve, Expert Says

YES: PRAMI Proved This - Time to Change the Guidelines!

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

MOC is an Unproven Initiative and a Waste of Time and Money!

MOC is Grounded in Learning/Education Theory and Improves Clinical Outcomes!

Social Media and the Internet: How to Make it Work for You and Your Career

PFO Closure for Stroke: A Call to Revise the Guidelines

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Updated US and EU Mitral Guidelines: Where Do They Agree and Disagree (and Why)?

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Guidelines for Commercial TAVR Site Selection in the United States

Medical Device Industry Perspectives

From Evidence-Based Medicine to Guidelines (and Appropriate Use Criteria) to Clinical Practice

Welcome and Introduction: The Purpose of the FDA Town Hall Meeting

Status Update on European Medical Device Regulatory Reform Initiatives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content